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Metabolic Bone Disease in Children 
Michael P. Whyte, MD* 
The first two presentations of this session concemed inborn errors of metabolism that present during infancy or child-
hood: carbonic anhydrase II deficiency, and hypophosphatasia. 
Each is a rare but instructive enzymopathy that impairs one 
"end" ofthe bone remodeling process. 
Osteopetrosis with Renal Ihbular Acidosis and 
Cerebral Calcification: The Carbonic Anhydrase 
II Deficiency Syndrome 
Sly (1) described how the autosomal recessive syndrome of 
osteopetrosis/renal tubular acidosis/cerebral calcification, first 
reported in 1972, was found in 1983 to be a new inborn error of 
metabolism. Selective absence of the carbonic anhydrase II (CA 
II) isoenzyme was discovered in patient erythrocytes, and half-
normal CA 11 levels were demonstrated in the red cells of obli-
gate carriers. Deficiency of this isoenzyme remains to be shown 
in bone and kidney tissue. Thirty patients have been reported to 
date. Clinical expressivity is variable but generally resembles 
"intermediate" forms of osteopetrosis. Radiographs show a de-
velopmental form of generalized osteosclerosis with features 
typical of osteopetrosis that may improve with aging; cerebral 
calcification is widespread on computed tomography. Most pa-
tients have both a proximal and distal renal tubular acidosis. His-
topathologic study of bone reveals evidence of unresorbed pri-
mary spongiosa—a characteristic feature of all human forms of 
osteopetrosis. Sly discussed what this new inborn error of me-
tabolism reveals conceming the physiological role of CA I I , in-
cluding a likely function in osteoclast-mediated bone 
resorption. 
Pediatric Forms of Hypophosphatasia 
Hypophosphatasia is an inheritable form of rickets/os-
teomalacia that is characterized by deficient activity of the tissue 
nonspecific (liver/bone/kidney) isoenzyme of alkaline phos-
phatase (TNSALP); placental and intestinal ALP activity is un-
affected (2). Clinical expressivity is extremely variable and 
ranges from intrauterine death from profound skeletal under-
mineralization to onset of recurrent, slowly healing stress frac-
tures in adult life. Premature loss of deciduous teeth is the most 
sensitive clinical manifestation in children. Rickets occurs 
although serum levels of calcium and phosphate are not sub-
normal. There is no effective medical treatment for hypo-
phosphatasia, but early prenatal diagnosis of severe forms is 
possible. Three phosphocompounds—phosphoethanolamine, 
inorganic pyrophosphate (PPi), and pyridoxal-5'-phosphate 
(PLP)—accumulate endogenously. The recent discovery that 
plasma PLP levels are elevated in all patients with hypo-
phosphatasia indicates that TNSALP functions as an ecto-
enzyme to regulate extracellular, but not intracellular, levels of 
a variety of phosphocompounds. Identification in 1988 of a 
missense mutation in the TNSALP gene in a patient with classic 
perinatal (lethal) hypophosphatasia provides unequivocal evi-
dence for a role for TNSALP in skeletal mineralization. Ab-
sence of ecto-TNS ALP activity results in extracellular ac-
cumulation of PPi, an inhibitor of hydroxyapatite crystal 
formation, which could account for the defective skeletal miner-
alization (2). 
Williams Syndrome 
Chesney (3) described the Williams syndrome. Affected chil-
dren characteristically have a variety of phenotypic abnor-
malities including elfin facies, microcephaly, stellate iris, epi-
canthal folds, and cardiac defects including supravalvular aortic 
stenosis. Mental deficiency and characteristic personality traits 
help to make patients relatively easy to identify. Hypercalcemia 
occurs in about 15% of subjects and is associated with failure to 
thrive, calcification of the media of blood vessels, hyper-
calciuria, and nephrocalcinosis. The Williams syndrome is gen-
erally a sporadic disorder, but familial cases have been reported. 
Chesney reviewed what is known about the pathophysiology of 
the hypercalcemia, including evidence for enhanced sensitivity 
to vitamin D with excessive intestinal absorption of calcium and 
evidence for a possible defect in calcitropic hormone regulation, 
since clearance of intravenously administered calcium is de-
creased in the Williams syndrome. 
The Molecular Basis of Clinical Heterogeneity in 
Osteogenesis Imperfecta 
Byers et al (4) discussed the molecular basis for the clinical 
heterogeneity of osteogenesis imperfecta (01). It is now clear 
that most clinical forms of OI result from mutations that affect 
the expression or structure of the genes that form type I col-
lagen. Following a description of type 1 collagen biosynthesis, 
Byers et al summarized the specific biochemical and molecular 
defects which have thus far been shown to cause the various 
clinical (Sillence) types of 01. In addition to the rare instances of 
gene deletion or large rearrangements, more commonly a vari-
ety of point mutations are now being identified in the different 
forms. Previously it was believed that severe type I I 01 was in-
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herited as an autosomal recessive trait, but now it appears from 
molecular biological studies that this form results more com-
monly from sporadic mutation or, when siblings are affected, 
from genetic mosaicism. Accordingly, the occurrence risk is 
considerably less than the 25% for true autosomal recessive dis-
orders. The authors reviewed the relationship between the 
clinical phenotype in OI and the nature of the specific molecular 
defect. Our rapidly improving comprehension of the molecular 
basis for this clinically heterogenous disorder should help to di-
rect potential medical therapies for the various types of 01. 
Neonatal Disorders of Mineral Metabolism 
Hillman (5) reviewed the neonatal disorders of mineral me-
tabolism, including early and late neonatal hypocalcemia and 
mineralization problems in premature and term infants. Contro-
versies regarding the diagnostic criteria for early neonatal hy-
pocalcemia and the need for therapy were discussed. The neces-
sity of using biochemical criteria, based upon serum ionized 
calcium rather than total calcium determination, was empha-
sized. The mineral and hormonal changes of early and late neo-
natal hypocalcemia were reviewed, and the role of hypomag-
nesemia in the latter condition was emphasized. Hillman 
discussed how, in term infants, disorders of skeletal mineraliza-
tion are often related to vitamin D deficiency. However, in pre-
mature infants fed breast milk, osteopenia/rickets has resulted 
from inadequate delivery of mineral to the skeleton. She empha-
sized the role of both phosphoms and calcium supplementation 
for correction of this problem and reviewed areas where further 
research is necessary. Hillman's presentation was followed by an 
interesting discussion session which emphasized the role of pla-
cental function in regulating skeletal mineralization of the fetus. 
Vitamin D Resistant Hypophosphatemic Rickets: 
Pathogenesis and Medical IVeatment 
Glorieux (6) discussed the clinical expression, pathogenesis, 
and medical treatment of vitamin D resistant hypophosphatemic 
rickets (VDRR). Controversy continues as to whether this most 
common form of inherited rickets in North America results from 
the elaboration of a humoral factor that causes selective renal 
phosphate wasting or from a more generalized cellular defect 
that involves the gut and bone as well as kidney. The mouse 
model for VDRR continues to provide useful information. In 
1987, the gene for VDRR in humans was mapped to the distal 
part of the short arm of the X chromosome. Characterization of 
the aberrant gene and its product now becomes feasible. 
Glorieux described how phosphate supplementation together 
with administration of calcitriol has resulted in improved growth 
rate, radiographic healing of rickets, and, in some subjects, cor-
rection of the mineralization defect at trabecular bone surfaces. 
The discussion following Glorieux's presentation concerned 
how hyperparathyroidism provoked by phosphate supplementa-
tion can be minimized in VDRR and what effects this medical 
regimen has on the kidney of these patients. 
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